MedTrace Logo

A Novel Measurement Concept to Objectively Quantify Severity of Vocal and Speech Related Symptoms Associated With Parkinson's Disease

NCT05421832 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 91

Last updated 2025-07-24

No results posted yet for this study

Summary

The aim of this research program is to develop and validate a smartphone app-based digital measurement concept that:

* Objectively quantifies the severity of Parkinson's Disease (PD) related vocal and speech symptoms;
* Accurately and sensitively identifies vocal and speech abnormalities associated with the prodromal stage of PD.

Conditions

  • Parkinson Disease

Interventions

DEVICE

Digital Speech Application

A custom smartphone-based speech assessment tool to extract multiple hypothesis-driven acoustic features from patient speech in a real-life environment.

Sponsors & Collaborators

  • Koneksa Health

    collaborator INDUSTRY

  • Michael J. Fox Foundation for Parkinson's Research

    collaborator OTHER

  • Northwestern University

    lead OTHER

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-27
Primary Completion
2025-06-30
Completion
2025-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05421832 on ClinicalTrials.gov